SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009071
Filing Date
2020-08-04
Accepted
2020-08-04 08:01:36
Documents
68
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbbp-20200630x10q.htm   iXBRL 10-Q 1576067
2 EX-10.1 sbbp-20200630xex10d1.htm EX-10.1 103748
3 EX-10.2 sbbp-20200630xex10d2.htm EX-10.2 1616962
4 EX-10.3 sbbp-20200630xex10d3.htm EX-10.3 159424
5 EX-31.1 sbbp-20200630xex31d1.htm EX-31.1 11866
6 EX-31.2 sbbp-20200630xex31d2.htm EX-31.2 11863
7 EX-32.1 sbbp-20200630xex32d1.htm EX-32.1 11530
8 GRAPHIC sbbp-20200630xex10d1001.jpg GRAPHIC 631
  Complete submission text file 0001558370-20-009071.txt   8041845

Data Files

Seq Description Document Type Size
9 EX-101.SCH sbbp-20200630.xsd EX-101.SCH 44244
10 EX-101.CAL sbbp-20200630_cal.xml EX-101.CAL 47927
11 EX-101.DEF sbbp-20200630_def.xml EX-101.DEF 148677
12 EX-101.LAB sbbp-20200630_lab.xml EX-101.LAB 436969
13 EX-101.PRE sbbp-20200630_pre.xml EX-101.PRE 304002
14 EXTRACTED XBRL INSTANCE DOCUMENT sbbp-20200630x10q_htm.xml XML 959076
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 10-Q | Act: 34 | File No.: 001-37569 | Film No.: 201071005
SIC: 2834 Pharmaceutical Preparations